In a total of 41 endometrial tissue samples, the relationship between telomerase activity and proliferating cell nuclear antigen (PCNA) labelling index was studied. In samples of endometrium from the proliferative phase of the menstrual cycle, telomerase activity was found in 15 out of 17 cases (88%). Two samples from the early proliferative phase showed negative telomerase activity and a low PCNA labelling index. However, three out of 16 samples of early secretory phase endometrium showed telomerase activity and a PCNA labelling index. In mid-to late secretory phase endometrium, in menopausal endometrium and in decidualized endometrium induced by progesterone neither telomerase activity nor PCNA labelling was found. These results suggest that telomerase activity of the endometrium may be correlated with the proliferative potential of the epithelial cells and that its activity may be regulated by oestrogen.
Introduction
Telomeres are specialized structures present at the distal end of chromosomes which have a function in chromosome protection, positioning, and replication (Blackburn, 1984; Zakian, 1989) . In vertebrates including humans, telomeres consist of tandem repeats of the sequence TTAGGG that spans up to 15 kb together with associated proteins (Moyzis et al., 1988; Meyne et al., 1989; Blackburn, 1991) . In every replicative event which takes place in a cell, the chromosome loses up to 200 nucleotides from its distal end (Allsopp et al., 1992; Vaziri et al., 1993) . This shortening of telomeres has been proposed to be the mitotic clock by which the cells count the number of their divisions, and a sufficiently short telomere provides the signal for replicative senescence in a normal cell (Hastie et al., 1990; Harley, 1991; Lindsey et al., 1991; Wright and Shay, 1992; Allsopp et al., 1995) .
Telomerase is a ribonucleoprotein that synthesizes telomeric DNA for addition to the end of the chromosome using a segment of its RNA component as a template (Greider and Blackburn, 1985; Greider and Blackburn, 1989; Yu et al., 1990) . Telomerase, therefore, counteracts the mitotic clock of telomere shortening. Most somatic cells are considered to lose telomerase activity during the early stage of embryogenesis. In contrast, a germ cell maintains the activity for the long time of the life span (DeLange, 1994) . Telomerase activity can be measured in vitro by a primer extension assay in which telomerase synthesizes telomeric repeats onto oligonucleotide primers (Kim et al., 1994) . Using this method, telomerase activity has been measured in a variety of tissues and cells. To date, most cancer cells, immortal cells and germ line cells have been shown to possess telomerase activity, unlike most normal somatic cells (Counter et al., 1994; Hiyama et al., 1995a,b) .
The endometrium shows markedly morphological and functional changes during the menstrual cycle. Quantitative and qualitative changes in a variety of proteins have been found during the menstrual cycle (Tabibzadeh et al., 1995a (Tabibzadeh et al., ,b, 1996 . These changes are evoked by sex steroid hormones that are produced in the ovary. These induce the transcription of many genes in the endometrium and may have an effect on telomerase. To investigate this hypothesis, we studied the activity of telomerase in the endometrium during the menstrual cycle.
Materials and methods

Patients
A total of 41 tissue samples were obtained from 17 cases of proliferative endometrium, 16 cases of secretory endometrium, five cases of post-menopausal endometrium, and three cases of decidualized endometrium. The age of each group (mean Ϯ SD) was 40.0 Ϯ 4.2, 41.9 Ϯ 3.3, 66.5 Ϯ 9.0, and 39.7 Ϯ 3.5 years respectively. The differences were not statistically significant, with the exception of the post-menopausal endometrium group. All patients underwent hysterectomy for benign gynaecological disorders, including adenomyosis, uterine leiomyoma and uterine prolapse. The cases of decidualized endometrium had received progestogens (medroxyprogesterone acetate for 3-4 weeks, n ϭ 2; norethindrone for 4 weeks, n ϭ 1) for the control of bleeding associated with uterine leiomyoma. All five post-menopausal cases had never received hormone replacement therapy. The tissues were removed from the resected uterus immediately after surgery, snap-frozen in liquid nitrogen and stored at -80°C until the study.
Endometrial dating was determined from the histology of the endometrium (Noyes et al., 1950) and classified into six phases of the menstrual cycle (early proliferative, mid-proliferative, late proliferative, early secretory, mid-secretory, and late secretory phase).
Preparation of tissue samples
Frozen samples were crushed into small pieces in liquid nitrogen. Each sample of~100 mg of frozen tissue was washed in ice-cold buffer (l0 mM HEPES-KOH, pH 7.5, 1.5 mM MgCl 2 , 10 mM KCl, and 1 mM dithiothreitol), and homogenized in 200 µl of a cell lysis buffer (10 mM Tris-HCl, pH 7.5, 1 mM MgCl 2 , 1 mM ethylene glycol-bis (β-aminoethyl ether) N,N,NЈ,NЈ,-tetraacetic acid (EGTA), 0.1 mM phenylmethylsulphonyl fluoride, 5 mM β-mercaptoethanol, 0.5% 3-(3-cholamidopropyl) dimethylammonio)-1-propanesulphonate (CHAPS; Wako Chemical Industries Inc, Osaka, Japan), 10% glycerol, and incubated on ice for 30 min. Cell homogenates were then centrifuged at 100 000 g for 30 min at 4°C. The supernatant was recovered, snap-frozen in liquid nitrogen and stored at -80°C. The concentration of protein was measured with Coomassie Brilliant Blue G-250 (Bio-Rad Laboratories, Hercules, CA, USA). Fetal bovine serum albumin was used as a standard.
Telomerase assay
The assay for telomerase activity was performed according to Kim et al. (1994) . To overcome the effect of the inhibitor to Taq DNA polymerase which is sometimes present in tissue extracts, we used an internal telomerase assay standard (ITAS) (Wright et al., 1995) . Briefly, 0.1 µg of CX primer (CCCTTACCCTTACCCTTACCCTAA) was lyophilized in a 0.5 ml microtube and sealed with molten wax (Ampliwax; Perkin-Elmer Japan Inc, Urayasu, Japan). The reaction mix consisted of 0.1 µg of TS Primer (AATCCGTCGAGCAGAGTT), 1 µg of T4 gene 32 protein (Amersham International plc, Amersham, UK), 50 µM of dNTP mix, 0.4 µl of [α-32 P]-dCTP, 2.5IU Taq DNA polymerase in 20 mM Tris-HCl, pH 8.3, 1 mM MgCl 2 , 63 mM KCl, and 1 mM EGTA. Polymerase chain reaction (PCR) was carried out as follows; denaturing at 94°C for 30 s; annealing at 50°C for 50 s; extension at 72°C for 1 min; for a total of 31 cycles. PCR products were electrophoresed in 12% polyacrylamide gel and autoradiographed. For each assay, an extract of AN3CA, an endometrial cell line, was used as a positive control. Cell lysis buffer was used as the negative control. All experiments were performed in duplicate.
Immunohistochemical staining of PCNA Tissue samples were submitted to immunohistochemical staining for proliferating cell nuclear antigen (PCNA) using anti-PCNA monoclonal antibody clone PC10 (Dako Japan Inc, Kyoto, Japan), according to the manufacturer's instructions. The tissue pieces were fixed in 10% phosphate-buffered formalin for 3 days, and embedded in paraffin. Sections of 3 µm thickness were obtained and deparaffinized. After being rinsed with phosphate-buffered saline (PBS) three times, the sections were microwaved at 1200 W for 5 min in distilled water (preliminary investigations had shown that staining was unsatisfactory in the absence of microwaving). The sections were incubated with 0.3% hydrogen peroxide for 15 min at room temperature, rinsed with PBS twice and then incubated with undiluted horseradish peroxidase coupled anti-PCNA monoclonal antibody overnight. After three rinses with PBS, the immunocomplex was visualized with 3,3Ј-diaminobenzidine (Sigma Chemical Company, St Louis, MO, USA). The sections were counterstained with 1% haematoxylin for 5 min. For each section, at least three fields were selected randomly, and over 100 epithelial cells in each field were selected and viewed. The PCNA immunoreactivity was studied by three different investig- Figure 1 . Autoradiography of telomerase assay of the endometrium, representative of duplicate experiments. Lanes 1-6, early proliferative endometria; lanes 7-12, mid-proliferative endometria; lanes 13-17, late proliferative endometria; and lanes 18-23, early secretory endometria. Telomerase activity was observed as a ladder of fragments at 6 base intervals. In all lanes, internal telomerase assay standard (ITAS) of 150 bp can be observed.
ators; PCNA labelling index was expressed as the percentage of positive cells.
Results
Telomerase activity
The autoradiographic results of the assay for telomerase activity in endometrium are shown in Figure 1 . Telomerase activity could be found as a ladder of bands at 6 base intervals. Of 41 surgically-resected endometria, 18 samples showed telomerase activity. Telomerase activity was found in 15 out of 17 proliferative endometria (88%), but in only three out of 16 secretory endometria (19%). Two samples of the proliferative endometrium with negative telomerase activity were categorized as early proliferative phase from the histological findings. However, three samples of secretory endometrium with positive telomerase activity were categorized as early secretory phase. Neither post-menopausal nor decidualized endometrium showed telomerase activity.
Since the protein concentration of the tissue extracts was likely to differ among groups, we determined the protein concentration of each sample. The protein concentrations of the proliferative endometrium, the secretory endometrium, the post-menopausal endometrium, and the decidualized endometrium were (mean Ϯ SD) 519 Ϯ 110, 365 Ϯ 157, 527 Ϯ 48 and 310 Ϯ 44 µg/ml respectively. Since the protein concentration in tissue extracts of the proliferative endometrium was significantly higher than that of the secretory or decidualized endometrium (P Ͻ 0.01), we analysed telomerase activity in extracts of proliferative endometrium, which were diluted with the same volume of cell lysis buffer. Telomerase activity was again found in all of the samples that had showed the activity previously (data not shown). Thus, we concluded that telomerase activity of the proliferative endometrium was significantly higher than that of the secretory endometrium or the decidualized endometrium.
Relationship between PCNA status and telomerase activity
PCNA immunoreactivity was observed in the nucleus of the endometrial epithelial and stromal cells (Figure 2 ). The frequency of positivity of PCNA staining varied from gland to gland; we analysed a minimum of nine fields of view in each section, and each was assessed by three independent investigators. In the stromal cells, positive PCNA staining was consistently observed throughout the menstrual cycle. High PCNA labelling was observed not only in late proliferative phase, but also in late secretory phase. PCNA labelling of the epithelial cells increased during the proliferative phase with a highest peak at the late proliferative phase and then decreased sharply in the secretory phase (Figure 3) .
In the early proliferative phase, the labelling index (expressed as a percentage of positive cells) of PCNA of the epithelial cells was 1.2-6.5%. Telomerase activity was found in four out of six samples (67%). In the samples in which telomerase activity could not be found, the PCNA labelling indices were less than those of the telomerase-positive samples. The endometria of the mid-prolifrative and late proliferative phases showed a high PCNA labelling index and positive telomerase activity.
In secretory endometrium, the PCNA labelling index of the epithelial cells was reduced. Telomerase activity was detected only in some samples of the early secretory phase. Neither telomerase activity nor PCNA labelling was found in mid-or late secretory endometrium. Neither post-menopausal endometrium nor decidualized endometrium had high PCNA labelling.
Discussion
In the present study, we have demonstrated the presence of telomerase activity in the endometrium. In reproductive tissues, germ line cells have been shown to possess telomerase activity (DeLange, 1994) . The endometrium is an essential tissue for reproduction; however, its embryogenesis is different from that of germ line cells. Therefore, the fact that the endometrium has telomerase activity is not attributable to the embryological similarity of the endometrium and the germ line cells.
PCNA is a key cell-cycle regulatory protein.
As an accessory protein of the DNA polymerase δ, it plays an important role in DNA repair and replication. It is expressed throughout the whole cell cycle in proliferating cells (Sawtell et al., 1995) . Since the antigenicity of PCNA is conserved in formalin-fixed and paraffin-embedded sections, the immunohistochemical expression of PCNA has been studied over the past years. It has been shown that the labelling index of PCNA correlates well with BrdU labelling (Lohr et al., 1995; Tinnemans et al., 1995; Moriki et al., 1996) , thymidine labelling (Battersby and Andersson, 1990) , the number of mitoses (Haerslev and Jacobsen, 1994) , and the number of proliferative fractions obtained by flow cytometry (Garcia et al., 1989; Siitonen et al., 1993) . Hence, PCNA appears to be valid as a marker of proliferation activity.
PCNA shows different staining characteristics depending upon the conditions used for fixation (Yu et al., 1992) , as well as in the different types of neoplasm (Hall et al., 1990) . The immunoreactivity of PCNA also depends on the duration of tissue fixation in formalin (Hall et al., 1990) . It has been shown that PCNA immunoreactivity in non-neoplastic tissues is greatly reduced after 48 hours of fixation in formalin and is virtually abolished after fixation for 72 h. However, PCNA immunoreactivity has been demonstrated to be retrieved by microwave treatment (Haerslev et al., 1996) . According to their protocol, we microwaved sections in distilled water and observed PCNA immunoreactivity in all sections. Although our results of PCNA labelling in endometrial epithelial cells throughout the menstrual cycle are in complete agreement with those of Li et al. (1993) , the ratio of positive immunoreactivity of PCNA is still lower than that previously reported by Cameron et al. (1996) . This may be due to the longer fixation in formalin performed in our study.
The endometrium is composed of multi-cellular components. In the present study, we focused only upon the endometrial epithelial cells, although the stromal cells are known to show proliferative potential in late proliferative phase and late secretory phase (Li et al., 1993) . However, the appearance of telomerase activity in the endometrium did not correlate with the proliferative potential of the stromal cells. The majority of somatic cells have been reported not to contain telomerase activity, which suggests that the epithelial cells of the endometrium are the most likely to possess telomerase activity.
Recent studies have demonstrated that the telomerase activity of tumour cells is associated with the cell cycle stage (Holt et al., 1996; Zhu et al., 1996) . A quiescent cancer cell in the G o phase of the cell cycle shows no detectable telomerase activity, whilst cells in the S phase have the highest telomerase activity. As shown in the present study, telomerase activity of the endometrium is quite compatible with that of tumor cells. The endometrium has a great proliferative potential during the follicular phase of the ovulatory cycle. The proliferative potential of the endometrium is, in a sense, no less than that of endometrial carcinomas. For a span of Ͼ30 years in females of reproductive age, the endometrium regularly proliferates following the action of oestrogens. If the endometrium has no telomerase activity, it cannot maintain its proliferative potential for such a long period. Therefore, the presence of telomerase in the endometrium may be essential for female reproduction.
The proliferation of the endometrium is controlled primarily by oestrogen, especially oestradiol. It is currently believed that oestrogen diffuses into the nucleus of target cells, binds to an oestrogen receptor forming a homodimer, and undergoes a conformational change, before binding to the oestrogenresponsive element of chromosomal DNA (Krett, 1994) . Consequently, oestradiol induces the transcription of a variety of genes, leading to the proliferation of target cells.
Progesterone antagonizes oestrogen action. The progesterone receptor induced by oestrogen in target cells is a prerequisite for progesterone to exert its action. The progesterone receptor complex suppresses oestrogenic action by at least three mechanisms: (i) reducing the rate of oestrogen receptor synthesis (Tseng and Gurpide, 1975) ; (ii) increasing the activity of the enzyme oestradiol dehydrogenase that coverts oestradiol into oestrone, a less potent oestrogen (Tseng and Gurpide, 1974) ; (iii) causing oestrogen sulphurylation (Tseng and Liu, 1981) . Thus, progesterone stops oestrogen-induced cell proliferation.
Results from this study suggest that telomerase activity in the endometrium may be related to the proliferative potential of the endothelial cells and, hence, possibly also subject to oestrgen regulation.
Persistent oestrogen exposure is associated with endometrial carcinogenesis. To date, Ͼ90% of cancer cells have been shown to possess telomerase activity and restoration of the telomerase activity of the neoplastic cells is considered to be a significant step in carcinogenesis. We studied the telomerase activity of endometrial carcinomas and found that most endometrial carcinoma tissue has telomerase activity (unpublished data). Hence, persistent oestrogen exposure may be involved in the endometrial carcinogenesis not only by promoting cell proliferation but also by activating telomerase.
